Previous 10 | Next 10 |
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Aterian Inc. (ATER) is expected to report $-0.12 for Q3 2023
2023-11-07 12:13:42 ET More on Aterian Seeking Alpha’s Quant Rating on Aterian Historical earnings data for Aterian Financial information for Aterian For further details see: Aterian Q3 2023 Earnings Preview
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its second quarter 2023 financial results after the market close on Wednesday, November 8, 2023, and plans to host a conference call for investors and interes...
2023-10-24 17:08:52 ET More on Aterian Aterian, Inc. (ATER) Q2 2023 Earnings Call Transcript Aterian: Sell On Delayed Profitability Expectations And Likelihood Of Near-Term Dilution For further details see: Aterian secures extension to regain compliance with Nasd...
NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced that it received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company a 180-day e...
NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced management’s participation in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13 at the Lotte New York Pal...
2023-08-08 21:00:27 ET Aterian, Inc. (ATER) Q2 2023 Earnings Conference Call August 08, 2023 05:00 PM ET Company Participants Ilya Grozovsky - Vice President, Investor Relations and Corporate Development Joseph A. Risico - Co-CEO Arturo Rodriguez - Co-CEO and CFO...
2023-08-08 16:21:46 ET Aterian press release ( NASDAQ: ATER ): Q2 GAAP EPS of -$0.45 misses by $0.30 . Revenue of $35.26M (-39.5% Y/Y) misses by $3.1M . Outlook: For the third quarter, taking into account the current global environment and inflation, we bel...
NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the second quarter ended June 30, 2023. Second Quarter Highlights Second quarter 2023 net revenue declined 39.5% to $35...
News, Short Squeeze, Breakout and More Instantly...
Arturo Rodriguez Appointed CEO Josh Feldman Appointed CFO Second Quarter 2024 Net Revenue Range Improved to Between $23 Million to $26 Million Second Quarter 2024 Adjusted EBITDA Range Improved to Between a Loss of ($1.0) Million to $0.0 Million NEW YORK, June 26, ...
First Quarter Net Loss Improved by 80.0% Year Over Year and Adjusted EBITDA Loss Improved by 38.4% Affirms Second Half 2024 Adjusted EBITDA Profitability Target NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company&...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...